Literature DB >> 15359361

Reduced concentrations of several vitamins in normal weight patients with late-onset dementia of the Alzheimer type without vascular disease.

M Glasø1, G Nordbø, L Diep, T Bøhmer.   

Abstract

BACKGROUND: There is an uncertainty to what an extent initiation of late onset dementia of the Alzheimer type (DAT) is related to nutritional factors.
OBJECTIVE: To find any differences in nutrient concentrations between women (75-85 y), well-nourished with moderate DAT, and a control group, all without vascular disease.
DESIGN: A case control study assessing clinical, anthropometrical, biochemical and micronutrient characteristics of 20 DAT patients and 18 free-living healthy women.
RESULTS: Significant differences (* = p < 0.05) were found for the following nutrients, given in sequence (Mean (SD)) for controls and DAT patients, respectively: Thiamine (nmol/L): 11.7 (6.9), 7.1(3.7)*; Blood thiamine diphosphate (nmol/L): 86.0 (12.5), 65.8 (27.5)*; Pyridoxal-5-phosphate 90.2 (14), 24.8 (3.3)*; Cobalamin (nmol/L) 435(263), 350 (264)*; Homocysteine (mmol/L) 14.7 (1.3), 18.5 (1.6)*; Ascorbic acid (mmol/L) 77.7 (28), 46.2 (25)*; alpha-tocopherol (mmol/L) 38.2 (9.2), 27.1 (11.5)*; Serum and blood thiamine mono-phosphate and ascorbic acid in cerebrospinal fluid were significantly different as well. Age, BMI, MMSE, MADRS, 'Vascular Score ' and a set of other biochemical parameters were similar between the groups. Using logistic regression analysis, models for predicting the presence of DAT all contained pyridoxal-5-phosphate, and CSF-protein, in combination with either one of variables, age, ascorbic acid, retinol, alpha-tocopherol, homocysteine, thiamin-diphosphate, CSF-thiamin. All the models give complete separation between DAT and controls.
CONCLUSIONS: The presence of reduced concentrations of several vitamins in the DAT patients compared to the controls might indicate that these nutrients may contribute to the development of DAT.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15359361

Source DB:  PubMed          Journal:  J Nutr Health Aging        ISSN: 1279-7707            Impact factor:   4.075


  18 in total

1.  Seafood (wild and farmed) for the elderly: contribution to the dietary intakes of iodine, selenium, DHA and vitamins B12 and D.

Authors:  J M Bourre; P Paquotte
Journal:  J Nutr Health Aging       Date:  2008-03       Impact factor: 4.075

Review 2.  Therapeutic potential of vitamin E and its derivatives in traumatic brain injury-associated dementia.

Authors:  Jan Dobrovolny; Martin Smrcka; Julie Bienertova-Vasku
Journal:  Neurol Sci       Date:  2018-04-07       Impact factor: 3.307

3.  Benfotiamine and Cognitive Decline in Alzheimer's Disease: Results of a Randomized Placebo-Controlled Phase IIa Clinical Trial.

Authors:  Gary E Gibson; José A Luchsinger; Rosanna Cirio; Huanlian Chen; Jessica Franchino-Elder; Joseph A Hirsch; Lucien Bettendorff; Zhengming Chen; Sarah A Flowers; Linda M Gerber; Thomas Grandville; Nicole Schupf; Hui Xu; Yaakov Stern; Christian Habeck; Barry Jordan; Pasquale Fonzetti
Journal:  J Alzheimers Dis       Date:  2020       Impact factor: 4.472

4.  Exposure to pyrithiamine increases β-amyloid accumulation, Tau hyperphosphorylation, and glycogen synthase kinase-3 activity in the brain.

Authors:  Jing Zhao; Xiaojing Sun; Zhe Yu; Xiaoli Pan; Fenghua Gu; Jia Chen; Wenxin Dong; Lei Zhao; Chunjiu Zhong
Journal:  Neurotox Res       Date:  2010-06-22       Impact factor: 3.911

5.  Altered glutamate clearance in ascorbate deficient mice increases seizure susceptibility and contributes to cognitive impairment in APP/PSEN1 mice.

Authors:  Deborah J Mi; Shilpy Dixit; Timothy A Warner; John A Kennard; Daniel A Scharf; Eric S Kessler; Lisa M Moore; David C Consoli; Corey W Bown; Angeline J Eugene; Jing-Qiong Kang; Fiona E Harrison
Journal:  Neurobiol Aging       Date:  2018-08-07       Impact factor: 4.673

Review 6.  Ascorbic acid, cognitive function, and Alzheimer's disease: a current review and future direction.

Authors:  Gene L Bowman
Journal:  Biofactors       Date:  2012-03-15       Impact factor: 6.113

7.  Souvenaid®: a new approach to management of early Alzheimer's disease.

Authors:  C W Ritchie; J Bajwa; G Coleman; K Hope; R W Jones; M Lawton; M Marven; P Passmore
Journal:  J Nutr Health Aging       Date:  2014-03       Impact factor: 4.075

8.  Combined dietary folate, vitamin B-12, and vitamin B-6 intake influences plasma docosahexaenoic acid concentration in rats.

Authors:  Nick van Wijk; Carol J Watkins; Robert J J Hageman; John C W Sijben; Patrick G H J Kamphuis; Richard J Wurtman; Laus M Broersen
Journal:  Nutr Metab (Lond)       Date:  2012-05-30       Impact factor: 4.169

Review 9.  Ascorbic acid and the brain: rationale for the use against cognitive decline.

Authors:  Fiona E Harrison; Gene L Bowman; Maria Cristina Polidori
Journal:  Nutrients       Date:  2014-04-24       Impact factor: 5.717

Review 10.  The roles of biomarkers of oxidative stress and antioxidant in Alzheimer's disease: a systematic review.

Authors:  Ya-Ting Chang; Wen-Neng Chang; Nai-Wen Tsai; Chih-Cheng Huang; Chia-Te Kung; Yu-Jih Su; Wei-Che Lin; Ben-Chung Cheng; Chih-Min Su; Yi-Fang Chiang; Cheng-Hsien Lu
Journal:  Biomed Res Int       Date:  2014-05-14       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.